Radiation therapy remains a central modality in cancer treatment, but normal-tissue toxicity and long-term stochastic effects ...
Blue Moon Metals Inc. ("Blue Moon" or the "Company") , is pleased to provide an update on its fully integrated 2026 ...
In modern data analytics, unexpected anomalies and hidden data errors frequently skew corporate forecasting models and ...
Raina Penchansky and Ali Berman on helping human creators in the age of AI ...
Explore Boston Beer (NYSE:SAM), recent Russell 1000 reclassification, brewing operations, beverage portfolio, manufacturing ...
Inherited retinal degenerations are a diverse group of genetic disorders that result in progressive vision loss. Advances in ...
The six days of July have helped offset some of the rain deficit accumulated in June.
Investor Webinar to be held July 14, 2026 VANCOUVER, BC / ACCESS Newswire / July 7, 2026 / Marimaca Copper Corp. ("Marimaca ...
A series of explosive devices detonated near the hotel where French President Emmanuel Macron is staying in Damascus, ...
FDA's PDUFA goal date is November 1, 2026If approved, mitapivat is positioned to become the first oral PK activator for patients with sickle cell disease CAMBRIDGE, Mass., July 07, 2026 (GLOBE NEWSWIR ...
Background Janus kinase inhibitors (JAKis) are emerging therapies for SLE, but concerns regarding thromboembolic risk persist ...
Blur price prediction is trending as BLUR jumps 56% with 24H trading volume up 1188.79%. See what's driving the rally and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results